An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Investigational Drug Gaining Popularity Online
The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of rapid UK delivery. Vendors market the drug there before directing buyers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Professionals Express Worries
However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals administering products of unknown origin.
Some experts stated the demand for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, risking fines, prosecution or imprisonment.
Service Response and Content Removal
According to TikTok, the platform has taken down violative content and prohibited related hashtags and query recommendations. The company said it was dedicated to keeping the service safe and investing in enhancing enforcement strategies.
Digital Marketplace Operations
Investigations also discovered groups with up to nine thousand participants selling the experimental drug using the platform's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with numerous of users, populated with photos of weight loss, glowing testimonials and detailed guides for mixing or administering at home.
After moments of entering one group, a vendor shared WhatsApp details, where most purchases occur. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or past usage.
Item Information and Costs
Within these groups, posts display black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Service Moderation and Security Measures
A representative for Telegram stated it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting substances they can’t verify. Even if the science behind this drug is valid, these online products may not contain what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are highly risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has already seen patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”
Producer Statement
A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may subject users to potentially significant medical dangers”.
